API reference

Selegiline

CAS number
14611-51-9
Molecular formula
C13H17N
Molecular weight
187.28 g/mol
Selegiline — 2D structure
2D structure (PubChem)

About this molecule

A selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson's disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. (From AMA Drug Evaluations Annual, 1994, p385) The compound without isomeric designation is Deprenyl. [PubChem]

Source: Toxin and Toxin Target Database (T3DB), via PubChem.

Identifiers

IUPAC name
(2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine
InChIKey
MEZLKOACVSPNER-GFCCVEGCSA-N
SMILES
C[C@H](CC1=CC=CC=C1)N(C)CC#C
Other CAS numbers recorded
102741-42-4
PubChem CID
26757

Also known as

selegiline · L-Deprenalin · (-)-selegiline · L-Deprenyl · Selegilina · Selegilinum · (-)-Deprenil · L-Selegiline

Related entries in the range

Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.

Tell us the grade, the quantity and the market.

Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.

Telephone+98 21 8888 3325 · office hours 09:00–17:00, Tehran
OfficeHaniya Parsan Darou, 3rd floor, No. 326, Zafar Street, Africa Boulevard, Tehran 1968734974, Iran
Emailcontact@hanpars.com